Skip to content

Effect of dietary management on women with polycystic ovary syndrome (PCOS)

Impact of Nutrition Intervention on Clinical and Metabolic Outcomes in Women with Polycystic Ovary Syndrome - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062534
Enrollment
20
Registered
2024-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Efficacy of functional food-based formulation (snack bar) in women with polycystic ovary syndrome: Type of Intervention: Omega-3 rich, functional food-based formulation (snack bar). Mo

Sponsors

Shraddha S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women diagnosed with polycystic ovary syndrome as per Rotterdam criteria 2003 with the presence of at least two of the following findings: hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Willingness to participate, and residents of Mysuru. Women who did not consume omega-3 or any other nutraceutical supplements in the last 3 months or followed a special diet and did not use tobacco.

Exclusion criteria

Exclusion criteria: Subjects with hyper-prolactinemia, congenital adrenal hyperplasia, androgen-secreting neoplasm, Cushing’s syndrome, attenuated 21-hydroxylase deficiency (as per Rotterdam criteria), as well as a history of diabetes or any other chronic disorders in the last 6 months, thyroid dysfunction, a history of at least 2 weeks of infection, trauma or surgery, or significant stress such as bereavement, psychiatric comorbidity, etc., will be excluded. Pregnancy and lactation. Women on contraceptive pills. History of allergy to nuts, flaxseeds or sesame seeds.

Design outcomes

Primary

MeasureTime frame
HOMA-IRTimepoint: At baseline and 6th week

Secondary

MeasureTime frame
Body composition by InBody 770 multifrequency bioelectrical impedance method.Timepoint: At baseline, 3rd week and 6th week;Depression by PHQ9. Anxiety by GAD7.Timepoint: At baseline and 6th week;Dietary data assessed using 3-days 24Hr recall and food frequency questionnaireTimepoint: At baseline, 3rd week and 6th week;Hirsutism assessed by modified-Ferriman-Gallwey score as perceived by the subjectsTimepoint: At baseline and 6th week;HOMA-IR by equation. Fasting insulin by ELISA. Fasting sugar by glucometer.Timepoint: At baseline, 3rd week and 6th week;Inflammatory marker- CRP by immunoturbidimetry.Timepoint: At baseline, 3rd week and 6th week;Lipid profile- total cholesterol, HDL-C, triglycerides by enzymatic kit method; LDL-C- Martin-Hopkins equation.Timepoint: At baseline, 3rd week and 6th week;Oxidative stress markers: malondialdehyde by TBARS assay, total antioxidant capacity by FRAP assay, serum uric acid by enzymatic kit method.Timepoint: At baseline, 3rd week and 6th week;Quality of life by health related PCOSQ scale (L. Cronin et al) licensed by McMaster UniversityTimepoint: At baseline and 6th week

Countries

India

Contacts

Public ContactShraddha S

Department of Studies in Food Science and Nutrition, University of Mysore

asnaurooj@foodsci.uni-mysore.ac.in9448489334

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026